Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
02335.HK
MICOT PHARMA-B (02335.HK): MT200605 Gets Phase III Ethics Approval
Tags:
Micot Pharma-B
02335.HK
Government Funding
2026-11-05
Offshore Trust Insight | MICOT PHARMA-B (02335.HK) First-Half R&D Expenses Up 215.9% YoY, Cumulative Decline of About 46% Since Stock Connect Inclusion
Tags:
Micot Pharma-B
02335.HK
Offshore Trust
2026-10-27
HK Recently Listed Stocks Watch | MICOT PHARMA-B (02335.HK): 1H R&D Expenses Up 215.9% YoY, 24.681 Million Cornerstone Lock-up Shares to Be Unlocked on December 24
Tags:
HK Recently Listed Stocks
Micot Pharma-B
02335.HK
2026-10-13
MICOT PHARMA-B (02335.HK): H shares included in eligible list under Stock Connect
Tags:
Micot Pharma-B
02335.HK
Stock Connect
2026-09-07
Micot (02335.HK): Phase‑II Clinical Trial of MT200605 for Acute Ischemic Stroke Completed, AKI Incidence Reduced by Over 80% in High‑dose Cohort
Tags:
Micot
02335.HK
2026-08-27
MICOT PHARMA-B (02335.HK): To Be Included as Hang Seng Composite Index Constituent with Effect from 7 September
Tags:
Micot Pharma-B
02335.HK
Index Inclusion
2026-08-24
MICOT PHARMA-B (02335.HK): Three XTL6001 Studies Accepted for Presentation at EASD 2026 and ASN Kidney Week 2026, Triple-Agonist Mechanism Gains International Recognition
Tags:
Micot Pharma-B
02335.HK
Research Progress
2026-08-17
MICOT PHARMA-B (02335.HK): Preclinical and Phase I data of neuroprotective candidate MT200605 accepted for oral presentation at 2026 World Stroke Congress; Phase II meets primary endpoint
Tags:
Micot Pharma-B
02335.HK
R&D Progress
2026-08-11
Shaanxi Micot Pharmaceutical Technology (02335.HK): Phase II Trial of MT200605 for Acute Ischemic Stroke Meets Primary Endpoint
Tags:
Shaanxi Micot Pharmaceutical Technology
02335.HK
2026-08-04
Shaanxi Micot Pharmaceutical Technology Co., Ltd (02335.HK): Phase II Clinical Study of Dual-Function Antithrombotic Candidate MT1002 for Anticoagulation in Haemodialysis Completes First Patient Enrolment
Tags:
Micot Pharma
02335.HK
Clinical Trial
2026-07-09
MICOT PHARMA-B(02335.HK) closed 102.75% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends
Tags:
Micot Pharma-B
02335.HK
2026-06-24
Micot Pharma-B (02335.HK): Grey Market Surges 84.18% to HK$33.52
Tags:
Micot Pharma-B
02335.HK
Grey Market
IPO
2026-06-23
Micot Pharma-B (02335.HK) Launches IPO: Max Offer Price at HK$21.0, Entry Fee Around HK$4,242 per Lot
Tags:
Micot Pharma
02335.HK
IPO
2026-06-15
Finance
IMPACT THERAP-B (07630.HK): EU Approves Senaparib for Ovarian Cancer
Finance
BANKOFZHENGZHOU (06196.HK): Redeems RMB10bn Perpetual Capital Bonds
Research
HK Stock Connect Daily Report: AKESO -22.11% after FDA CRL - 20261116
Research
Hong Kong Recently Listed Stocks Daily Report: METALIGHT Rises 32.27% to Lead, Computing Power Chip Theme Heats Up-20261116
Research
HK AI Concept Stock Daily: MINIMAX-W -18.04%; UBTECH JV Deal 20261116
Finance
SIHUAN PHARM (00460.HK): bireociclib indication added to national NRDL
Finance
51WORLD (06651.HK): kicks off Shenzhen A-share IPO with adviser
Finance
YANGTZEKIANG (00294.HK): interim loss seen down to HKD 13 million
Research
Offshore Trust Insight | LUK FOOK HOLD (00590.HK) Reports FY2025/26 Revenue of HKD 17.205 Billion; Founder Trust Holds About 40.65%
Finance
NewTimeSpace | HK Close: HSI +0.49%, Food & Consumer Themes Rise
Scan QR Code
Download App